CVS Pharmacy Technician Certification Practice Test

What does the iPledge program aim to eliminate?

1. Fetal exposure to isosorbide

2. Fetal exposure to isotretinoin

3. Fetal exposure to insulin

4. Fetal exposure to ipratropium HCl

The correct answer is: Fetal exposure to isotretinoin

The iPledge program is specifically designed to eliminate the risk of fetal exposure to isotretinoin, a potent medication used predominantly for severe acne. Due to isotretinoin's high teratogenic potential, meaning it can cause significant birth defects if taken during pregnancy, the program implements strict regulations and monitoring to ensure that women of childbearing age use effective contraception while on the medication and undergo regular pregnancy testing before and during treatment. This program is a crucial safety measure aimed at preventing serious health risks to developing fetuses linked to isotretinoin exposure, making this option the most relevant and accurate choice in this context. Other options mentioned do not correspond to the objectives of the iPledge program, as they relate to different medications or conditions that are not under the purview of this specific initiative.